- Related:
- Elevated LVEDP or LV filling pressures at rest or with exercise in the context of a preserved ejection fraction (≥ 50%)
- HFpEF should be thought of as a diagnosis of exclusion. After excluding the presence of depressed EF, assessing for HFpEF “masqueraders” is a critical step in evaluation, as each of the mimics have their own unique treatments that differ from the “garden variety” HFpEF.
- LV diastolic dysfunction is defined by an impairment in relaxation, an ↑ in viscoelastic chamber stiffness, or some combination of the two → symptomatic HF d/t ↑ filling pressures (at rest or with exertion).
- Elevated filling pressures → dyspnea, impaired exercise capacity, ↑ risk for HF hospitalization, and ↓ survival
- HFpEF is more than just LV diastolic dysfunction: 1
- subtle LV systolic dysfunction
- subtle impairments in systolic function at rest become dramatic during exercise in HFpEF → ↓ exercise capacity, impaired early diastolic recoil and LV suction, impaired cardiac output, and ↑ LV filling pressures
- LA impairment
- relative pericardial restraint
- abnormal right ventricular-pulmonary artery coupling
- pulmonary vascular disease (Pulmonary Hypertension)
- PH is extremely common in HFpEF, seen in roughly 80% of patients. Predominantly related to LA hypertension in most cases.
- ![[Heart Failure with Preserved Ejection Fraction HFpEF-1745700840071.webp|496x218]]
- systemic vascular stiffening
- coronary and peripheral microvascular dysfunction
- may contribute to subendocardial ischemia and impairments in LV longitudinal shortening during stress, especially in the setting of myocardial oxygen supply-demand imbalance
- chronotropic incompetence
- ![[Heart Failure with Preserved Ejection Fraction HFpEF-1745700533040.webp]]
- subtle LV systolic dysfunction
HFpEF Phenotypes
- Rather than having an isolated abnormality in left ventricular (LV) diastolic function, patients with HFpEF display multifaceted limitations in cardiac, vascular, and peripheral functions. 1
![[Heart Failure with Preserved Ejection Fraction HFpEF-1745699844214.webp]] Figure source 1
HFpEF Mimickers
| Differential Diagnosis | Echocardiographic Clues | Subsequent Testing Considered |
|---|---|---|
| Hypertrophic cardiomyopathy | Asymmetric hypertrophy; ↑↑LV wall thickness; LVOT obstruction; SAM | CMR, genetic testing |
| Restrictive cardiomyopathy | Small LV cavity; ↑LV wall thickness; sparkling myocardium, apical sparing; severely reduced tissue Doppler; PE; hepatic vein diastolic flow reversal during inspiration | CMR, biopsy, and others |
| Pulmonary arterial hypertension | ↑RVSP with no sign of elevated LV filling pressure (e.g., E/A ratio <1); isolated right heart dilation; PA dilation; RVOT Doppler midsystolic notch | Right heart catheterization; high-resolution CT |
| Constrictive pericarditis | Pericardial thickening; septal bounce; annulus paradoxus and annulus reversus; ↑respiratory variation in mitral/tricuspid flow; hepatic vein diastolic flow reversal during expiration; absence of IVC collapse | CT, CMR, right heart catheterization |
| Valvular heart disease | Morphological valvular abnormalities; color Doppler | Detailed echocardiographic assessments for stenosis/regurgitation; TEE |
| Coronary artery disease | Regional wall motion abnormality and thinning | Coronary angiography |
| Chronic thromboembolic pulmonary hypertension | Increased RVSP with no sign of elevated LV filling pressure; isolated right heart dilation; PA dilation; RVOT Doppler midsystolic notch | V/Q scan, high-resolution CT; right heart catheterization ± pulmonary angiography |
| High-output heart failure | Increased Doppler-derived cardiac output; increased 4 cardiac chamber volumes | Right heart catheterization |
Echo
- The combination of the E/e′ ratio and right ventricular systolic pressure has recently been shown to add independent value to the diagnostic evaluation of patients suspected of having HFpEF.
- HFpEF patients with microvascular dysfunction display more abnormal systolic mechanics by strain and tissue Doppler imaging
H2FPEF Score
![[Heart Failure with Preserved Ejection Fraction HFpEF-1745701551974.webp]]
Footnotes
-
Obokata M, Reddy YNV, Borlaug BA. Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: Understanding Mechanisms by Using Noninvasive Methods. JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):245-257. doi: 10.1016/j.jcmg.2018.12.034. Epub 2019 Jun 12. PMID: 31202759; PMCID: PMC6899218. ↩ ↩2 ↩3